Publications by authors named "Bo Oberg"

Claim this Profile
R
Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine.
Jolanta J Levenfors, Joakim Bjerketorp, Bengt Guss, Christina Nord, Sha Cao, Anders Broberg

J Antimicrob Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetramic acid based alkaloids from Roberg strain UP197 - antibiotic properties and new pyranterreones.
Christina Nord, Jolanta J Levenfors, Joakim Bjerketorp, Bengt Guss, Bo Öberg, Anders Broberg

Nat Prod Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-peptide amino acid racemization via inter-residue oxazoline intermediates during acidic hydrolysis.
Anders Broberg, Christina Nord, Jolanta J Levenfors, Joakim Bjerketorp, Bengt Guss

Amino Acids· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Isolation of Multidrug-Resistant spp., Producers of Novel Antibacterial Peptides.
Joakim Bjerketorp, Jolanta J Levenfors, Christina Nord, Bengt Guss, Bo Öberg, Anders Broberg

Front Microbiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial pyrrolidinyl and piperidinyl substituted 2,4-diacetylphloroglucinols from Pseudomonas protegens UP46.
Jolanta J Levenfors, Christina Nord, Joakim Bjerketorp, Jerry Ståhlberg, Rolf Larsson, Anders Broberg

J Antibiot (Tokyo)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isopedopeptins A-H: Cationic Cyclic Lipodepsipeptides from UP508 Targeting WHO Top-Priority Carbapenem-Resistant Bacteria.
Christina Nord, Joakim Bjerketorp, Jolanta J Levenfors, Sha Cao, Adam A Strömstedt, Anders Broberg

ACS Chem Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial Isoquinoline Alkaloids from the Fungus Em19.
Christina Nord, Jolanta J Levenfors, Joakim Bjerketorp, Christer Sahlberg, Bengt Guss, Anders Broberg

Molecules· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial 3,6-Disubstituted 4-Hydroxy-5,6-dihydro-2H-pyran-2-ones from Serratia plymuthica MF371-2.
Joakim Bjerketorp, Jolanta J Levenfors, Christer Sahlberg, Christina L Nord, Pierre F Andersson, Anders Broberg

J Nat Prod· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy.
Malin Elinder, Philippe Selhorst, Guido Vanham, Bo Oberg, Lotta Vrang

Biochem Pharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
Johan Harmenberg, Bo Oberg, Spotwood Spruance

Acta Derm Venereol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed].
Johan Lennerstrand, Kåre Bondeson, Anders Bergqvist, Jonas Blomberg, Bo Oberg

Lakartidningen· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
Tomasz I Michalak, Hong Zhang, Norma D Churchill, Torbjörn Larsson, Nils-Gunnar Johansson, Bo Oberg

Antimicrob Agents Chemother· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.
Suman K Vodnala, Marcela Ferella, Hilda Lundén-Miguel, Evans Betha, Nick van Reet, Bo Oberg

PLoS Negl Trop Dis· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for NNRTIs with slow dissociation and high affinity for a panel of HIV-1 RT variants.
Malin Elinder, Helena Nordström, Matthis Geitmann, Markku Hämäläinen, Lotta Vrang, Bo Oberg

J Biomol Screen· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of polymerase inhibitors as antiviral drugs.
Bo Oberg

Antiviral Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievements and challenges in antiviral drug discovery.
Eddy Littler, Bo Oberg

Antivir Chem Chemother· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
Joeri Auwerx, Miguel Stevens, An R Van Rompay, Louise E Bird, Jingshan Ren, Bo Oberg

J Virol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.
Christine Katlama, Jade Ghosn, Roland Tubiana, Marc Wirden, Marc-Antoine Valantin, Bo Oberg

AIDS· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
ME-609: a treatment for recurrent herpes simplex virus infections.
Johan G Harmenberg, Aftab R Awan, Stefan Alenius, Lars Ståhle, Anna C Erlandsson, Bo Oberg

Antivir Chem Chemother· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.
Hans O Andersson, Kerstin Fridborg, Seved Löwgren, Mathias Alterman, Anna Mühlman, Bo Oberg

Eur J Biochem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis